Inventor · disambiguated record
Anthony H. Cincotta
Also filed as: CINCOTTA ANTHONY · CINCOTTA ANTHONY H
89 granted patents·29 pending applications·3,021 citations·filing 1986–2025
99Inventor score
Files withVEROSCIENCE LLC48UNIV LOUISIANA STATE22CINCOTTA ANTHONY H12ERGO SCIENCE INC9GEN HOSPITAL CORP6
Top patents by PatentIndex Score
118 records- 0199US11560375B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2020·Granted Jan 24, 2023·6 cites·32 claims
- 0299US11241429B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2020·Granted Feb 8, 2022·10 cites·23 claims
- 0398US11883399B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2022·Granted Jan 30, 2024·5 cites·21 claims
- 0498US11607455B2Method for inducing tumor regressionVEROSCIENCE LLC·Filed 2020·Granted Mar 21, 2023·6 cites·20 claims
- 0598US11000522B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2020·Granted May 11, 2021·10 cites·24 claims
- 0698US10675282B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2019·Granted Jun 9, 2020·11 cites·18 claims
- 0797US11878974B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2021·Granted Jan 23, 2024·4 cites·31 claims
- 0897US10688094B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2019·Granted Jun 23, 2020·11 cites·30 claims
- 0997US9352025B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2014·Granted May 31, 2016·21 cites·19 claims
- 1096US11666567B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2021·Granted Jun 6, 2023·4 cites·22 claims
- 1196US11045464B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2016·Granted Jun 29, 2021·10 cites·21 claims
- 1296US10688155B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2018·Granted Jun 23, 2020·10 cites·57 claims
- 1396US9895422B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2016·Granted Feb 20, 2018·10 cites·19 claims
- 1496US9205084B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2013·Granted Dec 8, 2015·28 cites·17 claims
- 1596US9192576B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2013·Granted Nov 24, 2015·30 cites·54 claims
- 1696US8431155B1Bromocriptine formulationsCINCOTTA ANTHONY H·Filed 2012·Granted Apr 30, 2013·34 cites·29 claims
- 1796US6855707B2Method for the treatment of lipid and glucose metabolism disordersPLIVA D D·Filed 2001·Granted Feb 15, 2005·67 cites·14 claims
- 1895US10894791B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2017·Granted Jan 19, 2021·10 cites·12 claims
- 1995US10307421B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2018·Granted Jun 4, 2019·11 cites·25 claims
- 2095US10238653B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2017·Granted Mar 26, 2019·12 cites·10 claims
- 2195US9700555B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2016·Granted Jul 11, 2017·12 cites·100 claims
- 2295US8821915B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersCINCOTTA ANTHONY·Filed 2011·Granted Sep 2, 2014·37 cites·11 claims
- 2395US8741918B2Parenteral formulations of dopamine agonistsCINCOTTA ANTHONY H·Filed 2008·Granted Jun 3, 2014·33 cites·8 claims
- 2495US8137992B2Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereofCINCOTTA ANTHONY H·Filed 2011·Granted Mar 20, 2012·30 cites·3 claims
- 2595US7888310B2Methods of identifying responders to dopamine agonist therapyCINCOTTA ANTHONY H·Filed 2009·Granted Feb 15, 2011·30 cites·4 claims
- 2695US5344832AMethod for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebratesSUPERVISORS OF LOUISIANA UNIVE·Filed 1991·Granted Sep 6, 1994·94 cites·24 claims
- 2794US9993474B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2017·Granted Jun 12, 2018·11 cites·51 claims
- 2894US9925186B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2015·Granted Mar 27, 2018·11 cites·15 claims
- 2994US9522117B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2015·Granted Dec 20, 2016·12 cites·61 claims
- 3094US8877708B2Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disordersCINCOTTA ANTHONY H·Filed 2010·Granted Nov 4, 2014·30 cites·19 claims
- 3194US8613947B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2013·Granted Dec 24, 2013·32 cites·30 claims
- 3294US8137993B2Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereofCINCOTTA ANTHONY H·Filed 2011·Granted Mar 20, 2012·30 cites·4 claims
- 3394US8137994B2Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereofCINCOTTA ANTHONY H·Filed 2011·Granted Mar 20, 2012·30 cites·4 claims
- 3493US9999653B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersVEROSCIENCE LLC·Filed 2016·Granted Jun 19, 2018·11 cites·11 claims
- 3593US5714519AMethod for regulating glucose metabolismERGO SCIENCE INC·Filed 1995·Granted Feb 3, 1998·113 cites·27 claims
- 3693US5468755ATherapeutic process for the treatment of the pathologies of Type II diabetesUNIV LOUISIANA STATE·Filed 1993·Granted Nov 21, 1995·103 cites·39 claims
- 3792US11510921B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2018·Granted Nov 29, 2022·7 cites·12 claims
- 3892US8021681B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersCINCOTTA ANTHONY·Filed 2004·Granted Sep 20, 2011·39 cites·10 claims
- 3991US9415005B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2013·Granted Aug 16, 2016·13 cites·21 claims
- 4091US9364515B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersVEROSCIENCE LLC·Filed 2014·Granted Jun 14, 2016·13 cites·12 claims
- 4191US5877183ATreatment of lipid and glucose metabolism disorders with dopamine and serotonin agonistsERGO RESEARCH CORP·Filed 1997·Granted Mar 2, 1999·111 cites·21 claims
- 4291US5668155AAdministration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disordersGEN HOSPITAL CORP·Filed 1994·Granted Sep 16, 1997·65 cites·15 claims
- 4390US9655865B2Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetesCINCOTTA ANTHONY H·Filed 2008·Granted May 23, 2017·13 cites·5 claims
- 4489US10137132B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2014·Granted Nov 27, 2018·10 cites·10 claims
- 4589US5872127AMethod of regulating immune functionGEN HOSPITAL CORP·Filed 1997·Granted Feb 16, 1999·58 cites·23 claims
- 4689US5866584ATherapeutic process for the treatment of the pathologies of type II diabetesUNIV LOUISIANA STATE·Filed 1995·Granted Feb 2, 1999·79 cites·25 claims
- 4789US5696128AMethod of regulating immune functionUNIV LOUISIANA STATE·Filed 1994·Granted Dec 9, 1997·49 cites·25 claims
- 4889US5496803AProcess for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebratesUNIV LOUISIANA STATE·Filed 1994·Granted Mar 5, 1996·64 cites·13 claims
- 4988US5905083AMethod of treating rheumatoid arthritisUNIV LOUISIANA STATE·Filed 1995·Granted May 18, 1999·51 cites·32 claims
- 5088US5554623AMethod for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebratesERGO SCIENCE INC·Filed 1994·Granted Sep 10, 1996·54 cites·17 claims
Showing the top 50 of 118 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anthony H. Cincotta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →